Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

This study has been terminated.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Institut Claudius Regaud
ClinicalTrials.gov Identifier:
NCT00801151
First received: December 2, 2008
Last updated: May 19, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)